Global Anti-Thyroid Drugs Market to Reach $2.78 Billion by 2029, Growing at 2.7% CAGR

What Is the Expected Size and Growth Rate of the Anti-Thyroid Drugs Market?
There has been a consistent growth in the market size of anti-thyroid drugs in the past few years. The market size is projected to increase from $2.44 billion in 2024 to $2.5 billion in 2025, growing at a compound annual growth rate (CAGR) of 2.2%. Factors such as a rise in thyroid disorders, progress in drug development and healthcare infrastructure have contributed to this growth during the historical period.

Expectations are for a consistent rise in the size of the anti-thyroid drugs market in the upcoming years. It is projected to expand to $2.78 billion by 2029, with a compound annual growth rate (CAGR) of 2.7%. Factors contributing to this growth within the forecasted period include increased patient awareness and education, healthcare spending, patient demographics, and worldwide economic conditions. The prediction period anticipates significant trends such as alternatives to thyroid surgery and radioactive iodine, care that prioritizes patients, and telemedicine with remote monitoring.

What Factors Are Fueling Growth in the Anti-Thyroid Drugs Market?
Graves' disease, a predominant cause of hyperthyroidism, is seeing a surge in its incidence rate. The United States federal government's National Library of Medicine, a acclaimed biomedical library, highlights that Graves' disease (GD) is the leading cause of hyperthyroidism in the developed world. It tends to be more prevalent amongst individuals aged between 30 and 60, with women being 5-10 times more susceptible than men. The risk of GD is generally constituted of 79% genetic factors, while 21% is due to environmental influences. The escalating cases of Grave's disease are leading to an increase in the number of people dealing with hyperthyroidism. Consequently, it indicates a growing demand for anti-thyroid drugs, which, in turn, fuels the market growth.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

Which Leading Companies Are Shaping the Growth of the Anti-Thyroid Drugs Market?
Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

What Are the Major Trends Shaping the Anti-Thyroid Drugs Market?
Organizations focused on thyroid health are kick-starting efforts to raise awareness about thyroid disorders, provide updates on the latest treatment strategies, and share summaries of various thyroid disorder research findings. In the USA, almost 60% of individuals with hyperthyroidism are oblivious to their condition and remain unDiagnosed. To address these concerns, organizations such as the American Thyroid Association (ATA) are making a difference by informing people about thyroid disorders. Similar efforts for public enlightenment and awareness on thyroid diseases including hyperthyroidism, are being made by the Thyroid Foundation of Canada. Other institutions such as the American Academy of Otolaryngology and the British Thyroid Foundation are also rolling out initiatives and awareness drives in this respect.

What Are the Key Segments of the Anti-Thyroid Drugs Market?
The anti-thyroid drugs market covered in this report is segmented -

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)
2) By Route of Administration: Oral, Intravenous, Other Route Of Administration
3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:
1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil
2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol's Iodine Solution

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Which Region Dominates the Anti-Thyroid Drugs Market?
North America was the largest region in the anti-thyroid drugs market in 2023. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Is Covered In The Anti-Thyroid Drugs Global Market Report?

- Market Size Analysis: Analyze the Anti-Thyroid Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Anti-Thyroid Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Anti-Thyroid Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Anti-Thyroid Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3401

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.